I was on sidelines, but jumped in when it touched the base. I am already +ve and will have a stop limit just in case. But seems like there is not much bashing/shorting going on with this company. That is +ve.
You should have assume anyone who is watching these stocks will read those articles. Do you know the author and his experience?
"You can always pick one or two stocks where they actually lost but very few."
So this is one or two of those stocks!!!..
I think either it is Cognate or some other service provider. But bringing this same topic multiple times in multiple articles is just to make a -ve sentiment on NWBO a reason for shorts and to scare longs. Someone is for sure J about someone making some more money?
nice ...half the day and already reached average volume...is someone unloading or is it short attack?
Not a great article to push or make a short thesis. As someone twitted he complained about big investors and they got one now. What if there is another lined up?
When I looked at institutional holdings, I saw a lot of buying and less of selling. Seems like this stock might get shorted heavily again?
That is a very good question, as such there is no single answer.
I don't have many details, but the technology is still yet to be worked on and there is lot of funding needed.
But I don't think after the BK this is in such a bad shape.
Celldex organized the study for rindopepimut to be exploratory rather than for seeking regulatory approval, but the positive results led the company to say it is considering meeting with the FDA after the final data emerges in three to six months
Exploratory, meeting with FDA after three to six months..? There will be Law firms taking action soon.